ストックスクリーナーアプリを入手
1.11
4.72%
0.05
Tiziana Life Sciences Ltd (TLSA) 最新ニュース
TLSATiziana Life Sciences Ltd Com Latest Stock News & Market Updates - Stock Titan
Small cap wrap: Zero Candida, Midnight Sun Mining, Tiziana Life Sciences, Trust Stamp... - Proactive Investors
Tiziana Life Sciences begins patient dosing in Phase 2 MS trial at Johns Hopkins - Proactive financial news
Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab In Phase 2 Multiple Sclerosis Clinical Trial - MarketScreener
Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial - The Manila Times
Major Breakthrough: Johns Hopkins Launches Novel Nasal Treatment in Phase 2 MS Trial - Stock Titan
Tiziana Life Sciences begins dosing in trial of therapy for multiple sclerosis - Yahoo Finance
Small cap wrap: Northern Superior Resources, Tiziana Life Sciences, Alternus Clean Energy... - Proactive Investors
Multiple sclerosis Clinical Trials and Studies 2025: EMA, PDMA, - openPR
Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis Trial - The Manila Times
Yale Launches Groundbreaking Intranasal MS Treatment Trial: Tiziana's Innovation in Focus - Stock Titan
Tiziana Life Sciences begins dosing in Phase 2 trial for intranasal foralumab in SPMS - Proactive financial news
Tiziana Life Sciences Ltd Files For Mixed Shelf Of Up To $250 MillionSEC Filing -March 24, 2025 at 05:22 pm EDT - Marketscreener.com
Tiziana Life Sciences CEO to present at 37th Annual ROTH Conference - Proactive Investors UK
Tiziana Life Sciences to Present at the 37th Annual Roth Conference - The Manila Times
Tiziana Life Sciences Reveals Growth Strategy at Major ROTH ConferenceKey Updates Expected - StockTitan
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule - The Manila Times
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Requirements - Nasdaq
Tiziana Life Sciences Regains Compliance With Nasdaq Listing Minimum Bid Price Rule - MENAFN.COM
Tiziana Life Sciences Regains Nasdaq Compliance, Secures Continued Listing - TipRanks
Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential - Simply Wall St
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer's Disease - Informazione.it
Can Tiziana's Foralumab Enable Breakthroughs In Neuroinflammatory And Neurodegenerative Diseases? - RTTNews
Tiziana Life Sciences stock soars to 52-week high of $1.75 - Investing.com
Democrat-led states join legal fight over Trump's mass firings of federal workers -March 06, 2025 at 10:38 pm EST - Marketscreener.com
Tiziana Life Sciences Ltd. (NASDAQ: TLSA) Stock Hits Multi-Month High After Filing a Key IND with the FDA - DRP Journal
Tiziana: Foralumab Drug Development Presses On With Additional EAP Enrollment - Seeking Alpha
Sector Update: Health Care -March 04, 2025 at 03:39 pm EST - Marketscreener.com
Tiziana submits FDA investigational new drug application - Proactive Investors UK
Tiziana Life Sciences Files New Drug Application for ALS Drug Candidate -March 04, 2025 at 09:03 am EST - Marketscreener.com
Tiziana Life Sciences Advances ALS Treatment with FDA IND Submission - TipRanks
Tiziana Life Sciences Files Investigational New Drug Application With FDA For ALS Phase 2 Clinical Trial - Marketscreener.com
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial - The Manila Times
Could This Intranasal Therapy Change ALS Treatment? Tiziana Seeks FDA Approval - StockTitan
Tiziana Life Sciences Ltd (NASDAQ:TLSA) Sees Significant Drop in Short Interest - Defense World
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Why Tiziana Life Sciences Ltd (TLSA) is Skyrocketing So Far in 2025 - Insider Monkey
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey
Tiziana stock jumps 12% on TBI drug study publication - MSN
Tiziana Life Sciences' lead candidate demonstrates favorable safety profile and clinical response - Proactive Investors UK
Market movers: Ideal Power, Tiziana Life Sciences, Medicus Pharma... - Proactive financial news
Tiziana Life Sciences nasal anti-CD3 therapy shows promise in treating traumatic brain injury, study reveals - Proactive Investors UK
Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury - The Manila Times
Can Tiziana's Nasal Therapy Revolutionize Traumatic Brain Injury Treatment? New Study Says Yes - StockTitan
Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive… - Informazione.it
Small cap headlines: Candel Therapeutics, Sintana Energy, Trust Stamp, Tiziana Life Sciences... - Proactive financial news
Tiziana Life Sciences nearing completion of long COVID study on foralumab - Proactive Investors UK
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter - The Manila Times
Can This Nasal Therapy Solve Long COVID? Tiziana's Breakthrough Approach Targets Brain Inflammation - StockTitan
Stoke Therapeutics (NASDAQ:STOK) and Tiziana Life Sciences (NASDAQ:TLSA) Head to Head Survey - Defense World
2.00%
大文字化:
|
ボリューム (24 時間):